Suppr超能文献

N6-甲基腺苷RNA甲基化调节因子促进前列腺癌进展。

N6-methyladenosine RNA methylation regulators contribute to the progression of prostate cancer.

作者信息

Wu Qunying, Xie Xing, Huang Yiming, Meng Shanshan, Li Youcheng, Wang Huifeng, Hu Yanling

机构信息

Department of Biochemistry and Molecular Biology, School of Pre-Clinical Medicine, Guangxi Medical University, Nanning, Guangxi, 530021, China.

Life Sciences Institute, Guangxi Medical University, Nanning, Guangxi, 530021, China.

出版信息

J Cancer. 2021 Jan 1;12(3):682-692. doi: 10.7150/jca.46379. eCollection 2021.

Abstract

Prostate cancer (PCa) is one of the most common epithelial malignant tumors and the fifth leading cause of cancer death in men. An increasing number of studies have demonstrated that N6-methyladenosine (mA) plays a crucial role in tumorigenesis and tumor development. However, little is known about the role and levels of common mA regulators and mA levels in PCa. In this study, we analyzed the characteristic expression of mA regulators in PCa and castration-resistant prostate cancer (CRPC). UALCAN and cBioPortal were used to estimate the clinical value and genetic alterations of mA regulators, respectively. The correlation between mA regulators and androgen receptor (AR) was assessed using Gene Expression Profiling Interactive Analysis (GEPIA) by Pearson correlation statistics. Total mA levels were detected in transgenic adenocarcinoma of the mouse prostate (TRAMP) mice and PCa cell lines. Results showed that the expression of methyltransferase-like 3 (METTL3) and YTH domain family members, namely, YTHDC2, YTHDF1, and YTHDF2 were generally upregulated in PCa, whereas those of fat mass and obesity-associated protein (FTO), AlkB homolog 5 (ALKBH5), and methyltransferase-like 14 (METTL14) were downregulated. The expression of METTL3, METTL14, Wilms' tumor 1-associating protein (WTAP), YTHDC2, YTHDF1, and YTHDF2 were remarkably higher in CRPC with lymph node metastasis than that in CRPC with bone metastasis, whereas ALKBH5, FTO, and YTHDF3 significantly decreased in CRPC with lymph node metastasis tissues. YTHDF1, YTHDF2, and YTHDC2 were positively correlated with the Gleason grades of PCa, and METTL14, FTO, and ALKBH5 were negatively associated with the Gleason classification. MA regulators were positively correlated with AR. Patients with a genomic alteration of mA were associated with poor disease-free survival (DFS). The total mA levels in TRAMP mice increased dramatically compared with those in tumor-free mice, and mA levels in LNCaP cell lines were higher than DU145 and PC3 cell lines. In summary, METTL3, METTL14, ALKBH5, FTO, YTHDC2, YTHDF1, and YTHDF2 were abnormally expressed in PCa and related to Gleason classification. Changes in mA levels maybe contributed to the development and progression of PCa.

摘要

前列腺癌(PCa)是最常见的上皮性恶性肿瘤之一,也是男性癌症死亡的第五大主要原因。越来越多的研究表明,N6-甲基腺苷(m6A)在肿瘤发生和肿瘤发展中起关键作用。然而,关于常见m6A调节剂的作用和水平以及PCa中的m6A水平知之甚少。在本研究中,我们分析了m6A调节剂在PCa和去势抵抗性前列腺癌(CRPC)中的特征性表达。分别使用UALCAN和cBioPortal评估m6A调节剂的临床价值和基因改变。通过Pearson相关统计,使用基因表达谱交互分析(GEPIA)评估m6A调节剂与雄激素受体(AR)之间的相关性。在小鼠前列腺转基因腺癌(TRAMP)小鼠和PCa细胞系中检测总m6A水平。结果显示,甲基转移酶样3(METTL3)和YTH结构域家族成员,即YTHDC2、YTHDF1和YTHDF2在PCa中通常上调,而脂肪量和肥胖相关蛋白(FTO)、AlkB同源物5(ALKBH5)和甲基转移酶样14(METTL14)下调。METTL3、METTL14、威尔姆斯瘤1相关蛋白(WTAP)、YTHDC2、YTHDF1和YTHDF2在伴有淋巴结转移的CRPC中的表达明显高于伴有骨转移的CRPC,而ALKBH5、FTO和YTHDF3在伴有淋巴结转移组织的CRPC中显著降低。YTHDF1、YTHDF2和YTHDC2与PCa的Gleason分级呈正相关,而METTL14、FTO和ALKBH5与Gleason分级呈负相关。m6A调节剂与AR呈正相关。m6A基因改变的患者无病生存期(DFS)较差。与无肿瘤小鼠相比,TRAMP小鼠的总m6A水平显著升高,LNCaP细胞系中的m6A水平高于DU145和PC3细胞系。总之,METTL3、METTL14、ALKBH5、FTO、YTHDC2、YTHDF1和YTHDF2在PCa中异常表达并与Gleason分级相关。m6A水平的变化可能有助于PCa的发生和发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a17/7778550/520226fb8d60/jcav12p0682g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验